Literature DB >> 18421705

Sunlight ultraviolet irradiation and BRAF V600 mutagenesis in human melanoma.

Ahmad Besaratinia1, Gerd P Pfeifer.   

Abstract

The incidence of melanoma, the most lethal form of skin cancer, continues to increase in the Western world. In addition to genetic alterations in high- and low-susceptibility genes identified for melanoma, somatic mutations in BRAF gene occur frequently in human melanoma and are distinctively linked to sun exposure. Of significance is a single hotspot codon, i.e., BRAF V600, wherein up to 92% of all mutations arise. Recent work in our laboratory has demonstrated that solar ultraviolet (UV) irradiation triggers mutagenesis through induction of various DNA lesions, many of which capable of producing similar types of mutations, as those seen in BRAF V600 variants in human melanoma. In this review article, we have discussed application of "DNA damage-targeted mutagenicity" of solar UV-irradiation for determining the mechanistic involvement of sunlight UV in BRAF V600 mutagenesis in human melanoma. We envision that establishing "DNA-damage derived mutagenesis" in this exceptionally unique target gene may resolve the underlying mechanism(s) of melanoma-genesis, thus helping define preventive and therapeutic measures against this malignant disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18421705     DOI: 10.1002/humu.20802

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  14 in total

Review 1.  Melanoma: from mutations to medicine.

Authors:  Hensin Tsao; Lynda Chin; Levi A Garraway; David E Fisher
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

Review 2.  How sunlight causes melanoma.

Authors:  Lilit Garibyan; David E Fisher
Journal:  Curr Oncol Rep       Date:  2010-09       Impact factor: 5.075

3.  Clinicopathological features, vitamin D serological levels and prognosis in cutaneous melanoma of shield-sites: an update.

Authors:  Giovanni Paolino; Elisa Moliterni; Dario Didona; Valentina Garelli; Paola Corsetti; Teresa Lopez; Antonio Giovanni Richetta; Carmen Cantisani; Ugo Bottoni; Stefano Calvieri
Journal:  Med Oncol       Date:  2014-12-17       Impact factor: 3.064

Review 4.  UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer.

Authors:  Gerd P Pfeifer; Ahmad Besaratinia
Journal:  Photochem Photobiol Sci       Date:  2011-08-01       Impact factor: 3.982

Review 5.  Applications of the human p53 knock-in (Hupki) mouse model for human carcinogen testing.

Authors:  Ahmad Besaratinia; Gerd P Pfeifer
Journal:  FASEB J       Date:  2010-04-06       Impact factor: 5.191

Review 6.  The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.

Authors:  Boris C Bastian
Journal:  Annu Rev Pathol       Date:  2014       Impact factor: 23.472

7.  Cellular Senescence is a Common Characteristic Shared by Preneoplasic and Osteo-Arthritic Tissue.

Authors:  Jean-Marc Brondello; Didier Philipot; Farida Djouad; Christian Jorgensen; Danièle Noël
Journal:  Open Rheumatol J       Date:  2010-02-11

Review 8.  Evidence for the Role of Blue Light in the Development of Uveal Melanoma.

Authors:  Patrick Logan; Miguel Bernabeu; Alberto Ferreira; Miguel N Burnier
Journal:  J Ophthalmol       Date:  2015-05-17       Impact factor: 1.909

9.  Does melanoma begin in a melanocyte stem cell?

Authors:  James D Hoerter; Patrick Bradley; Alexandria Casillas; Danielle Chambers; Brandon Weiswasser; Lauren Clements; Sarah Gilbert; Albert Jiao
Journal:  J Skin Cancer       Date:  2012-12-18

10.  Synergistic targeted inhibition of MEK and dual PI3K/mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma.

Authors:  Bih-Rong Wei; Helen T Michael; Charles H C Halsey; Cody J Peer; Amit Adhikari; Jennifer E Dwyer; Shelley B Hoover; Rajaa El Meskini; Serguei Kozlov; Zoe Weaver Ohler; William D Figg; Glenn Merlino; R Mark Simpson
Journal:  Pigment Cell Melanoma Res       Date:  2016-09-22       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.